Synergistic proliferative action of insulin-like growth factor I and 17 β-estradiol in MCF-7S breast tumor cells

Experimental Cell Research

Volumn 273, Issue 1, 2002, Pages 107-117

  Hamelers, Irene H L ^a   Van Schaik, Richard F M A ^a   Van Teeffelen, Hetty A A M ^a   Sussenbach, John S ^a   Steenbergh, Paul H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Breast cancer; Cell cycle; Estradiol; IGF I; MCF 7S

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; ESTRADIOL; FULVESTRANT; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; RETINOBLASTOMA PROTEIN; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MITOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0036346061     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2001.5430     Document Type: Article

References (46)

1. Molecular mechanism of a cross-talk between estrogen and growth-factor signaling pathways
2. IGF system components as prognostic markers in breast cancer
3. Enhancement of insulin-like growth factor signaling in human breast cancer: Estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo
4. Type I insulin-like growth factor receptor function in breast cancer
5. Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: Synergistic action of insulin and estrogen
6. Mitogenic signaling of insulin-like growth factor I in MCF-7 human breast cancer cells requires phosphatidylinositol 3-kinase and is independent of mitogen-activated protein kinase
7. Stabilization of cyclin D1 mRNA via the phosphatidylinositol 3-kinase pathway in MCF-7 human breast cancer cells
8. Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells
9. Antiestrogen inhibition of cell cycle progression in breast cancer cells is associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation
10. Stimulation of human breast cancer MCF-7 cells with estrogen prevents cell cycle arrest by HMG-CoA reductase inhibitors
11. Multihormonal regulation of insulin-like growth factor-I-related protein in MCF-7 human breast cancer cells
12. Estrogen regulated messenger RNAs in human breast cancer cells
13. 1-arrested human breast cancer
14. The antiestrogen ICI 182, 780 inhibits proliferation of human breast cancer cells by interfering with multiple, sequential estrogen-regulated processes required for cell cycle completion
15. Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis
16. Role of AKT1 in 17β-estradiol- and insulin-like growth factor I (IGE-I)-dependent proliferation and prevention of apoptosis in MCF-7 breast carcinoma cells
17. The potentiation of estrogen on insulin-like growth factor I action in MCF-7 human breast cancer cells includes cell cycle components
18. Plasma membrane estrogen receptors signal to antiapoptosis in breast cancer
19. Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium
20. Rapid activation of MAP kinase by estrogen in the bone cell line
21. Non-transcriptional action of oestradiol and progestin triggers DNA synthesis
22. Modulation of the proliferative response of breast cancer cells to growth factors by oestrogen
23. Insulin receptor substrate-1 expression is regulated by estrogen in the MCF-7 human breast cancer cell line
24. Role of insulin-like growth factor-I in regulating estrogen receptor-alpha gene expression
25. Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells
26. Estrogen receptor alpha rapidly activates the IGF-1 receptor pathway
27. Role of estrogen-induced insulin-like growth factors in the proliferation of human breast cancer cells
28. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction
29. The role of MAP kinase in TPA-mediated cell cycle arrest of human breast cancer cells
30. 1-to-S transition
31. Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation
32. The retinoblastoma protein and cell cycle control
33. Transcriptional regulation during the mammalian cell cycle
34. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E- Cdk2
35. Estrogen receptors: Bioactivities and interactions with cell signaling pathways
36. The role of the IGF-I receptor in the growth and transformation of mammalian cells
37. Cytoskeleton alteration in MCF7R cells, a multidrug resistant human breast cancer cell line
38. Growth regulatory peptide production by human breast carcinoma cells
39. Analysis of Insulin-like growth factor I gene expression in malignancy: Evidence for a paracrine role in human breast cancer
40. Rac regulation of transformation, gene expression, and actin organization by multiple, PAK-independent pathways
41. Integration of Rac-dependent regulation of cyclin D1 transcription through a nuclear factor-kappaB-dependent pathway
42. Cyclin D1 triggers autonomous growth of breast cancer cells by governing cell cycle exit
43. Cyclins and cancer II: Cyclin D and CDK inhibitors come of age
44. Acute effects of growth factors on T-47D breast cancer cell cycle progression
45. 1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2
46. Inducicle overexpression of cyclin D1 in breast cancer cells reverses the growth-inhibitory effects of antiestrogens